Your fact-checks will appear here
The claim that COVID-19 vaccines have produced a global increase in cardiovascular complications and deaths
COVID-19 vaccines have been highly effective at preventing severe disease and death across studies, while protection against infection and symptomatic disease has been lower and wanes over months, esp...
Congressional committees—principally the House Select Subcommittee on the Coronavirus Pandemic and the House Oversight Committee—have released a mix of subpoenaed internal emails (notably from longtim...
Short-term ivermectin use at approved doses is generally associated with mild, self-limited effects — dizziness, headache, gastrointestinal upset, and transient skin reactions — while rare but serious...
There is no credible evidence that funded the invention of COVID-19; claims that he or his administration “created” or financed the virus are conspiracy-driven distortions of legitimate research grant...
Documented case reports of sodium chlorite / “Miracle Mineral Solution” () poisoning describe a consistent syndrome of oxidant injury—methemoglobinemia, hemolytic anemia, and acute kidney injury—with ...
Randomized trials of ivermectin for COVID-19 and other indications report adverse events spanning neurological, gastrointestinal, dermatologic, ocular, and systemic (including multiorgan failure) cate...
Randomized clinical trials and subsequent large-scale observational studies have repeatedly shown that substantially reduce symptomatic disease, hospitalization, intensive care use, and death, while h...
Yes: . Official tallies compiled by institutions such as recorded multi‑million global death totals as the pandemic unfolded— and climbing to over 6 million by March 2022—while researchers and agencie...
Les vaccins autorisés contre la ont montré une protection nette contre l’infection symptomatique et, surtout, contre les formes sévères, les hospitalisations et les décès dans de multiples études et m...
Large, well‑designed and subsequent large meta‑analyses have generally failed to find that ivermectin prevents hospitalization, speeds recovery, or reduces mortality from COVID‑19; smaller trials and ...
Documented risks of using veterinary ivermectin in humans center on overdose and neurotoxicity from large or repeated doses, with reported outcomes ranging from mild gastrointestinal or neurologic sym...
Several large population-level cohort analyses and registry studies have been published or completed that track cancer incidence after COVID‑19 vaccination — notably a South Korean national database a...
Poison control centers and emergency departments documented a clear uptick in human exposures to ivermectin during the COVID-19 era, with multiple case series and surveillance projects showing that ma...
A patchwork of randomized trials has evaluated ivermectin’s short‑term effects, but few registered RCTs explicitly set out to study long‑term safety; when long‑term endpoints are declared they most co...
Two well-controlled phase 3 trials of the recombinant protein vaccine NVX‑CoV2373 showed high clinical efficacy for a two‑dose primary series — about 89.7% against symptomatic COVID‑19 in the UK trial...
COVID-19 vaccination rates surged rapidly during the first year of availability, reached a clear peak in doses administered in 2021, and since that peak have shifted from mass primary-series campaigns...
The phrase "Indian woman in USA" is ambiguous: it can mean American Indian/Alaska Native (AI/AN) women or women of Indian (South Asian) origin classified within the Asian American population; the avai...
Clinical evidence does not establish a reliable prophylactic (prevention) dose of ivermectin for COVID‑19: trials and meta‑analyses report conflicting, low‑certainty results and major methodological c...
The preponderance of high-quality evidence shows COVID-19 vaccines have not driven a global rise in cardiovascular complications or deaths; instead, vaccines reduce COVID-19–related cardiovascular har...